Deng Zhi-kuan, Qian Gui-sheng, Cheng Sai-yu, Wu Jing
Department of Neurology, Second Affiliated Hospital, Third Military Medical University, Chongqing 400037, China.
Zhonghua Yi Xue Za Zhi. 2009 Oct 13;89(37):2639-43.
To observe the change of expression of vascular endothelial growth factor (VEGF) and vascular leakage in the brain of rats exposed to high altitude with siRNA targeting vascular endothelial growth factor and explore the pathological mechanism and preventive approach of high altitude cerebral edema (HACE).
Fifty male Wistar rats were divided randomly into normal control group (Ncon), high altitude control group (Hcon), intraventricular normal saline control group (Scon), intraventricular siRNA group (CVI) and intravenous siRNA group (IVI). Rats in Ncon were raised normally. Rats in Hcon, Scon, CVI and IVI pretreated with intravenous injection of normal saline, intraventricular injection of normal saline, intraventricular injection of siRNA and intravenous injection of siRNA respectively were exposed to a low-pressure cabin mimicking a high altitude of 7000 m for 24 h. The ratio of dry and wet brain weight was calculated and the sodium fluorescein leakage calculated to evaluate the cerebral edema and the blood brain barrier permeability. Also the real-time quantitative RT-PCR was employed to detect the expression of VEGF mRNA and the Western blot the expression of VEGF.
Compared with rats in NC, high altitude exposure led to a significant increase in the levels of VEGF mRNA (from 21.6 + or - 3.5 K copies/microg to 36.3 + or - 3.9 K copies/microg, P < 0.01) and protein (from 48 + or - 0.09 to 0.77 + or - 0.12, P < 0.01) in rat brain and fluorescence intensity of sodium fluorescein increased significantly (from 548 + or - 48 rfu/mg to 674 + or - 32 rfu/mg, P < 0.01). Intravenous injection of siRNA targeting to VEGF caused no significant change of expression VEGF mRNA and protein and fluorescence intensity of sodium fluorescein in rat brain (P > 0.05, respectively). While compared with rats in HC, intraventricular injection of siRNA targeting to VEGF caused the significant reduction of expression of VEGF mRNA (from 36.3 + or - 3.9 to 19.9 + or - 4.3, P < 0.01) and protein (from 0.77 + or - 0.12 to 0.44 + or - 0.13, P < 0.01) and fluorescence intensity of sodium fluorescein (from 674 + or - 32 rfu/mg to 542 + or - 77 rfu/mg, P < 0.05) in rat brain. There were no significant change in the ratio of dry and wet brain weight among five groups.
VEGF may play a key role in the pathologic process of HACE. Intraventricular injection of siRNA targeting to VEGF inhibits the expression of VEGF and prevent the high altitude-induced vascular leakage. These findings might provide a basis for new preventive approaches of cerebral edema.
采用靶向血管内皮生长因子(VEGF)的小干扰RNA(siRNA)观察高原暴露大鼠脑内VEGF表达及血管渗漏变化,探讨高原脑水肿(HACE)的病理机制及防治措施。
50只雄性Wistar大鼠随机分为正常对照组(Ncon)、高原对照组(Hcon)、脑室注射生理盐水对照组(Scon)、脑室注射siRNA组(CVI)和静脉注射siRNA组(IVI)。Ncon组大鼠常规饲养。Hcon、Scon、CVI和IVI组大鼠分别经静脉注射生理盐水、脑室注射生理盐水、脑室注射siRNA和静脉注射siRNA预处理后,置于模拟海拔7000m的低压舱内24h。计算脑干湿重比值,测定荧光素钠渗漏量,评估脑水肿及血脑屏障通透性;采用实时定量RT-PCR检测VEGF mRNA表达,蛋白质免疫印迹法检测VEGF蛋白表达。
与NC组比较,高原暴露后大鼠脑内VEGF mRNA水平(从21.6±3.5K拷贝/μg增至36.3±3.9K拷贝/μg,P<0.01)、蛋白水平(从48±0.09增至0.77±0.12,P<0.01)显著升高,荧光素钠荧光强度显著增强(从548±48rfu/mg增至674±32rfu/mg,P<0.01)。静脉注射靶向VEGF的siRNA后,大鼠脑内VEGF mRNA、蛋白表达及荧光素钠荧光强度无明显变化(P均>0.05)。与HC组比较,脑室注射靶向VEGF的siRNA后,大鼠脑内VEGF mRNA水平(从36.3±3.9降至19.9±4.3,P<0.01)、蛋白水平(从0.77±0.12降至0.44±0.13,P<0.01)及荧光素钠荧光强度(从674±32rfu/mg降至542±77rfu/mg,P<0.05)显著降低。五组脑干湿重比值无明显变化。
VEGF可能在HACE病理过程中起关键作用。脑室注射靶向VEGF的siRNA可抑制VEGF表达,减轻高原暴露所致的血管渗漏,为脑水肿防治提供新依据。